AR003470A1 - Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina - Google Patents

Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina

Info

Publication number
AR003470A1
AR003470A1 ARP960103779A AR10377996A AR003470A1 AR 003470 A1 AR003470 A1 AR 003470A1 AR P960103779 A ARP960103779 A AR P960103779A AR 10377996 A AR10377996 A AR 10377996A AR 003470 A1 AR003470 A1 AR 003470A1
Authority
AR
Argentina
Prior art keywords
salts
pharmaceutically acceptable
compositions
sinusitis
allergy
Prior art date
Application number
ARP960103779A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR003470A1 publication Critical patent/AR003470A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Abstract

Esta invención se refiere a composiciones y métodos para proporcionar tratamiento o atenuación mejorada de síntomas de resfríos, alergia, sinusitisy/o gripe, mediante la administración de una cantidad segura y eficaz de una composición que contiene un agente analgésico y agentes antihistamínicos deéter de pirrolidina y piperidina. Los activos farmacéuticos analgésicos útiles en las composiciones de esta invención incluyen aspirina y acetaminofeno asícomo drogas antiinflamatorias sin esteroides (NSAIDS) seleccionadas de las siguientes categorías: derivados de ácido propiónico; derivados de ácidoacético; derivados de ácido fenámico; derivados de ácido bifenilcarboxílico; y oxicamas. Ejemplos de activos farmacéuticos analgésicos útiles en estainvención incluyen, entre otros, acetaminofeno, ácido acetilsalicílico, ibuprofeno, fenbuprofeno, flurbiprofeno, indometacina, quetoprofeno, naproxeno,sus sales farmacéuticamente aceptables, sus enantiómeros y mezclas.Elacetaminofeno, ibuprofeno y naproxeno son especialmente preferidos para su usoen composiciones de esta invención. La expresión sales farmacéuticamente aceptables se refiere a sales preparadas a partir de bases no tóxicasfarmacéuticamente aceptables, incluyendo bases orgánicas e inorgánicas. Las sales derivadas de bases no orgánicas incluyen sales de sodio, potasio, litio,amonio, calcio, magnesio, ferrosa, de zinc, manganosa, de aluminio, férrica, mangánica, etc. Las sales derivadas de bases no tóxicas farmacéuticamenteaceptables incluyen sales de aminas primarias, secundarias, terciarias y cuaternarias, aminas sustituidas, incluyendo aminas sustituidas de origennatural,aminas cíclicas y resinas de cambio de ion básico,por ej. trietilamina, tripropilamina, 2-dimetilaminoetanol, 2-dietilaminoetanol, lisina, arginina,
ARP960103779A 1995-07-28 1996-07-26 Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina AR003470A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50877595A 1995-07-28 1995-07-28
US61152896A 1996-03-05 1996-03-05

Publications (1)

Publication Number Publication Date
AR003470A1 true AR003470A1 (es) 1998-08-05

Family

ID=27056302

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103779A AR003470A1 (es) 1995-07-28 1996-07-26 Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina

Country Status (8)

Country Link
EP (1) EP0841947A1 (es)
JP (1) JPH11510168A (es)
AR (1) AR003470A1 (es)
AU (1) AU6599196A (es)
CA (1) CA2227958A1 (es)
CO (1) CO4750820A1 (es)
PE (1) PE12098A1 (es)
WO (1) WO1997004808A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
EP1014983A1 (en) * 1997-09-19 2000-07-05 The Procter & Gamble Company Naproxen/cetirizine compositions and methods for treating respiratory disorders
DE60232445D1 (de) 2001-06-28 2009-07-09 Ucb Farchim Sa Cetirizin und pseudoephedrin enthaltende tablette
KR20040045429A (ko) * 2001-09-04 2004-06-01 베링거 인겔하임 인터내셔날 게엠베하 항인플루엔자 약제
TWI313598B (en) 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
RU2286770C2 (ru) * 2004-11-22 2006-11-10 Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (ЗАО "НПО "Антивирал") Антигриппозное средство
JP5598108B2 (ja) * 2009-07-09 2014-10-01 ライオン株式会社 内服用固形組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU8764191A (en) * 1990-09-28 1992-04-28 Mcneill-Ppc Inc. Ibuprofen-antihistamine combinations
ATE183640T1 (de) * 1991-11-19 1999-09-15 Univ Virginia Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
GB9222849D0 (en) * 1992-10-31 1992-12-16 Smithkline Beecham Plc Novel use of pharmaceutical compositions
EP0674517A1 (en) * 1992-12-21 1995-10-04 The Procter & Gamble Company Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen

Also Published As

Publication number Publication date
PE12098A1 (es) 1998-04-19
CO4750820A1 (es) 1999-03-31
AU6599196A (en) 1997-02-26
EP0841947A1 (en) 1998-05-20
WO1997004808A1 (en) 1997-02-13
JPH11510168A (ja) 1999-09-07
CA2227958A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
Mauleón et al. Preclinical and clinical development of dexketoprofen
EP0311677B1 (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
AR064895A2 (es) Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina
AR003470A1 (es) Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina
JP6397100B2 (ja) ロキソプロフェンを含有する医薬組成物3
JP2763634B2 (ja) 開始上促進された/増強された無痛覚
ES2397262T3 (es) Composiciones líquidas de absorción rápida que contienen una amina y un AINE
SE7910371L (sv) Oralt intagbart lekemedel med inflammationshemmande verkan
Ligumsky et al. Rectal Administration of Nonsteroidal Andinflammatory Drugs: Effect on Rat Gastric Ulcerogenicity and Prostaglandin E2 Synthesis
KR920016086A (ko) 흡입용의 반응억제성 천식치료 활성을 갖는 비스테로이드성 소염제
AR012376A1 (es) Formulacion de gel para la aplicacion topica
NO20001290L (no) Multiple-enhet sammensetninger av ikke-steroid anti- inflammatorisk medikament substans (NSAID) med modifisert frigjøring
US5968974A (en) Method of treating colonic adenomas
CO5280050A1 (es) Desnaturalizantes para las sales aminas simpaticomimeticas
CO6180502A2 (es) Comprimido masticable que contiene fenilefrina
UY24816A1 (es) Sulfonamidas agonistas de prostaglandinas para la prevención y restauración de la masa ósea
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
BR0212155A (pt) Composição farmacêutica
FR2385398A1 (fr) Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate
KR970705390A (ko) 비마약성 진통제(non-narcotic analgesic) 및 진통효과 향상제(analgesia enhancer)를 포함하는 통증 완화 조성물(COMPOSITION ALLEVIATING PAIN, CONTAINING A NON-NARCOTIC ANALGESIC AND AN ANALGESIA ENHANCER)
Aabakken Small-bowel side-effects of non-steroidal anti-inflammatory drugs
PT805157E (pt) Derivados do indole e sua utilizacao medicinal
CA2411960A1 (en) Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
RU2015112586A (ru) Фармацевтические композиции, содержащие флурбипрофен